Actemra close to US approval

August 8, 2008
Sales and Marketing

US regulars have recommended Roche's Actemra (tocilizumab) be approved to treat adults with moderate to severe rheumatoid arthritis (RA). The …

Latest news from Datamonitor

August 5, 2008
Research and Development, Sales and Marketing

Biovest/Accentia's BiovaxID revives hope for therapeutic cancer vaccines Biovest, a subsidiary of Accentia, has announced positive data from a pivotal …

Currency lifts Wyeth to 5% growth

July 31, 2008
Sales and Marketing

Wyeth saw revenues increase 5% in the second quarter of the year to $5.9 billion, contributing to six month sales …

Sanofi boosts vaccines pipeline with Acambis acquisition

July 31, 2008
Sales and Marketing

Sanofi-Aventis has snapped up UK biotech Acambis for £276 million, gaining access to an early-stage pipeline of vaccine candidates targeting …

Lilly’s second quarter marred by prasugrel delay

July 31, 2008
Sales and Marketing

A delay to a key new product took the shine off Lilly's strong second quarter, which saw sales increase 11% …

Sanofi sees off rival for Czech generic company

July 31, 2008
Sales and Marketing

Sanofi-Aventis' proposed takeover of Zentiva is a step closer to success after its only rival for the Czech generics company …

Sanofi underperforms in second quarter

July 31, 2008
Sales and Marketing

Sanofi-Aventis had a below par second quarter and faces a generic threat to sales of top-selling drug Plavix in Germany. …

AstraZeneca boosted by Crestor sales

July 31, 2008
Sales and Marketing

AstraZeneca's second quarter sales increased by 9% to $8 billion, as it rode out a 4% drop in US sales …

A new kind of patient advocate

July 30, 2008
Sales and Marketing Cancer, campaigner, market access, patient

When I came to interview Kate Spall, it was she, not I, who fired the first few questions. Her approach …

Scepticism over

July 29, 2008

NICE will receive a record £100 million from the government in attempt to end the UK's postcode lottery and speed …

The organisational generation gap

July 28, 2008
Business Services careers, generations, recruitment

If you look at your organisation carefully, it is likely you will find three or even four generations represented among …

Latest news from Datamonitor

July 28, 2008
Sales and Marketing Genentech, Roche

Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …

Pharma-Patient group relationships

July 24, 2008
Research and Development, Sales and Marketing industry relations, patient groups, pharma

In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …

Generics giant formed as Teva acquires Barr

July 24, 2008
Sales and Marketing generics

Teva is to buy rival firm Barr for $7.5 billion to create a new giant in the global generics industry. …

Roche acquires gene therapy specialists Mirus

July 24, 2008
Sales and Marketing

Roche has bought Mirus Bio for $125 million, a move which it believes will put it at the forefront of …

Pfizer thrives despite US slowdown

July 24, 2008
Sales and Marketing

Pfizer has posted strong second quarter results despite underwhelming performance from its US operations. Outside the US Pfizer's revenue rose …

National movement’ needed to tackle obesity

July 24, 2008

Local communities, businesses, charities and other groups need to come together in a 'national movement' in order to tackle the …

Latest news from Datamonitor

July 21, 2008
Sales and Marketing

Immunisation against S. aureus has potential in selected target groups Staphylococcus aureus bacteria have become a key concern in both …

The Gateway to Local Adoption Series

Latest content